Cover Image

Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Tarek Hassanein, Andrew P. Keaveny, Parvez Mantry, Alastair D. Smith, Michael P. McRae, John Kittelson, Steve Helmke, Gregory T. Everson
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
by: Tarek Hassanein, et al.
Published: (2024)

Featured Cover
by: Tarek Hassanein, et al.
Published: (2024)

Editorial: Reading the cholate – A new gateway to portal hypertension and oesophageal varices
by: Iulia Minciuna, et al.
Published: (2024)

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT‐V Study
by: Mitchell Shiffman, et al.
Published: (2024)

Editorial: Eosinophilic oesophagitis coming of age—Increasing frequency and wider age range—Authors' reply
by: Akshatha Kiran, et al.
Published: (2024)

Letter: Potential impact ofHelicobacter pyloriinfection on oesophageal disorders in chronic liver disease—Authors' reply
by: Francisco Idalsoaga, et al.
Published: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply'
by: Francesco Calabrese, et al.
Published: (2024)

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply
by: Sagnik Biswas, et al.
Published: (2024)

Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply
by: Sagnik Biswas, et al.
Published: (2024)

Editorial: Quantity is important! Authors' reply
by: Marika Rudler, et al.
Published: (2024)

Letter: Dietary emulsifiers and intestinal health—The beginning of an evolving story: Authors’ reply
by: Jessica A. Fitzpatrick, et al.
Published: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
by: Jessica A. Fitzpatrick, et al.
Published: (2024)

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision? Authors' reply
by: María José García, et al.
Published: (2024)

Letter: Irritable bowel syndrome and antibiotics—Authors' reply
by: Kyle Staller, et al.
Published: (2024)

Editorial: Another brick in the CDST wall: Authors' reply
by: Kyuwon Kim, et al.
Published: (2024)

Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood—Authors' reply
by: Mikkel Malham, et al.
Published: (2024)

Editorial: Crystalising the burden of steatotic liver disease—Authors' reply
by: Carolin V. Schneider, et al.
Published: (2024)

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
by: Benedikt Silvester Hofer, et al.
Published: (2024)

Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions—Authors' reply
by: María José García, et al.
Published: (2024)

Editorial: The microbiome and gastric mucosal protection in aspirin users—Authors' reply
by: Nina Løn, et al.
Published: (2024)

Letter: The enigma of angiotensin receptor blocker‐associated enteropathy—Authors' reply
by: Annalisa Schiepatti, et al.
Published: (2024)

Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study
by: Maria Mironova, et al.
Published: (2024)

Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
by: Matthias Lenfant, et al.
Published: (2024)

Editorial: Can we predict or not predict response to hypnotherapy? That is the question. Authors' reply
by: Dipesh H. Vasant, et al.
Published: (2024)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply
by: Abhinav Vasudevan, et al.
Published: (2024)

Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights. Authors' reply
by: Matthias Lenfant, et al.
Published: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—an emulated clinical trial. Authors' reply
by: Elliot B. Tapper, et al.
Published: (2024)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply
by: Linda Henry, et al.
Published: (2024)

Editorial: Genetics for non‐invasive risk stratification—Finding the needle in the haystack? Authors' reply
by: Lana Bridi, et al.
Published: (2024)

Editorial: Sonographic assessment of colonic content—A new tool for constipation? Authors' reply
by: R. M. Mathias, et al.
Published: (2024)

Letter: Association between terlipressin and multidrug‐resistant organism rectal colonization: Authors' reply
by: Marcus M. Mücke, et al.
Published: (2024)

Editorial: High qHBsAg—Is it a good or bad signal? Authors' reply
by: Hsin‐Che Lin, et al.
Published: (2024)

Editorial: Hepatitis C virus eradication improves skeletal muscle mass—Authors' reply
by: Marta Paula Pereira Coelho, et al.
Published: (2024)

Editorial: Mucosal healing with steroids—Once upon a time in ulcerative colitis. Authors' reply
by: Tomohiro Fukuda, et al.
Published: (2024)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B—Author's reply
by: Hyeyeon Hong, et al.
Published: (2024)

Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world—Authors' reply
by: Manya Prasad, et al.
Published: (2024)

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
by: Stuart McPherson, et al.
Published: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
by: Eunice X. X. Tan, et al.
Published: (2024)

Editorial: Updated epidemiology of steatotic liver disease in people withHIVin the United States—Authors' reply
by: Samer Gawrieh, et al.
Published: (2024)

Letter: Potential confounders might exaggerate the risk of rheumatoid arthritis in patients with microscopic colitis—Authors' reply
by: David Bergman, et al.
Published: (2024)